高敏心肌肌钙蛋白T报告、临床结局与医疗资源使用
该研究为历史对照的队列研究,纳入澳大利亚南澳大利亚州所有公立急诊科在2020年2月1日至2021年2月28日期间、报告方式改变前后6个月内接受hs-cTnT检测的18岁及以上患者,共40921例。暴露为将hs-cTnT报告至最低定量限(非 masking 报告组20206例)与常规肌钙蛋白报告(20715例)。结果显示非 masking 报告组急诊出院率更高(45.2% vs 39.0%,P<.001),中位住院时间更短(7.68小时 vs 7.92小时,P<.001),心肌梗死诊断、冠状动脉造影、经皮冠状动脉介入治疗或冠状动脉旁路移植术无差异,12个月全因死亡、心肌梗死和心肌损伤复合终点相似(校正HR 0.95,95%CI 0.90-1.01,P=.09)。结论认为该报告方式不增加诊断或操作,可能改善医疗资源使用。
要点
- 非 masking 报告hs-cTnT至最低定量限组急诊出院率为45.2%,常规报告组为39.0%(P<.001)。
- 非 masking 报告组中位住院时间为7.68小时(IQR 4.32-46.80),常规报告组为7.92小时(IQR 4.56-49.92),P<.001。
- 两组心肌梗死诊断、冠状动脉造影、经皮冠状动脉介入治疗或冠状动脉旁路移植术无差异。
- 12个月全因死亡、心肌梗死和心肌损伤复合终点相似(校正HR 0.95,95%CI 0.90-1.01,P=.09)。
适用人群与场景
- 18岁及以上、在南澳大利亚州任何公立急诊科就诊、在肌钙蛋白报告方式改变前后6个月内接受hs-cTnT检测的患者。
- 数据收集时间为2020年2月1日至2021年2月28日。
研究设计与关键结果
- 研究设计为历史对照的基线-随访队列研究,比较将hs-cTnT报告至最低定量限与常规肌钙蛋白报告后的临床结局,采用逆概率治疗加权校正患者特征。
- 共纳入40921例患者,非 masking hs-cTnT报告组20206例(中位年龄62.0岁,IQR 46.0-77.0;女性10120例,50.1%),常规肌钙蛋白报告组20715例(中位年龄63.0岁,IQR 47.0-77.0;男性10752例,51.9%)。
- 非 masking hs-cTnT报告与更高的急诊出院率相关(45.2% vs 39.0%;P<.001)。
- 非 masking hs-cTnT报告与更短的中位住院时间相关(7.68小时,IQR 4.32-46.80 vs 7.92小时,IQR 4.56-49.92;P<.001)。
- 心肌梗死诊断、冠状动脉造影、经皮冠状动脉介入治疗或冠状动脉旁路移植术无差异。
- 12个月全因死亡、心肌梗死和心肌损伤复合终点相似(校正HR 0.95;95%CI 0.90-1.01;P=.09)。
证据类型、等级与局限
- 证据类型:队列研究(历史对照设计)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,将hs-cTnT结果报告至最低定量限与心肌梗死诊断、有创冠状动脉操作或12个月伤害增加无关,但可能与改善医院资源使用相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Despite being recommended by clinical guidelines, substantial concerns remain regarding the use of high-sensitivity cardiac troponin assays and whether it is associated with increased resource use, myocardial infarction (MI) or myocardial injury diagnoses, and procedural rates.
OBJECTIVE: To characterize the association of reporting high-sensitivity cardiac troponin T (hs-cTnT) to the lowest limit of quantification vs conventional troponin reporting with clinical outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used a historically controlled baseline and follow-up design to compare clinical outcomes after changing hs-cTnT reporting to the lowest limit of quantification. All patients aged 18 years or older presenting to any public emergency department (ED) in the state of South Australia between February 1, 2020, and February 28, 2021, who had an hs-cTnT test in the 6 months before and after the change in troponin reporting practice were included. Outcomes were assessed after adjusting for patient characteristics using inverse probability treatment weighting. The data analysis was performed between May 1, 2022, and July 27, 2023.
EXPOSURE: hs-cTcnT reporting.
MAIN OUTCOMES AND MEASURES: The main outcomes were frequency of diagnosed MI, coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft (CABG); hospital length of stay; and ED discharge rate as measured using time-to-event Cox regression models. The secondary outcome was the composite 12-month event rate of all-cause mortality, MI, and myocardial injury.
RESULTS: A total of 40 921 patients were included, of whom 20 206 were included in the unmasked hs-cTnT reporting group (median [IQR] age, 62.0 [46.0-77.0]; 10 120 females [50.1%]) and 20 715 were included in the conventional troponin reporting group (median [IQR] age, 63.0 [47.0-77.0] years; 10 752 males [51.9%]). Unmasked hs-cTnT reporting was associated with higher ED discharge rates (45.2% vs 39.0%; P < .001) and a shorter median hospital length of stay (7.68 [IQR, 4.32-46.80] hours vs 7.92 [IQR, 4.56-49.92] hours; P < .001). There was no difference in diagnosis of MI, coronary angiography, percutaneous coronary intervention, or coronary artery bypass graft. The composite of all-cause mortality, MI, and myocardial injury at 12 months was similar (adjusted hazard ratio, 0.95; 95% CI, 0.90-1.01; P = .09).
CONCLUSIONS AND RELEVANCE: This cohort study found that unrestricted reporting of hs-cTnT results to the lowest limit of quantification was not associated with an increase in the diagnosis of MI, invasive coronary procedures, or harm at 12 months but may be associated with improved hospital resource use.
参考来源
- Nguyen MT, Lambrakis K, Lehman S, et al. High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use. JAMA Netw Open. 2024. PMID: 39405063. doi:10.1001/jamanetworkopen.2024.38541
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。